Liminal BioSciencesPulmonary fibrosisidiopathic pulmonary fibrosispirfenidone
…as reported. Phase 3 development was stopped after the sponsor, Liminal BioSciences, shifted focus to sodium phenylbutyrate, which was also discont…
1articles mentioning funders
2funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: Liminal BioSciences ×
Liminal BioSciences
This funder is selected. Its supporting articles are shown below.